This is the authors' abstract. We don't add key points for this paper.
OBJECTIVE: Stenosis at the terminal portion of the internal carotid artery (ICA) is a characteristic feature of moyamoya disease (MMD). However, MMD may develop in patients with initially preserved terminal ICAs, and the lesion distribution and predictors of progression during the pre-moyamoya stage remain poorly defined. METHODS: We conducted a single-center retrospective longitudinal cohort study of consecutive patients with intracranial arterial stenosis (ICAS) in the anterior circulation to characterize the pre-moyamoya stage of MMD, including the distribution of initial lesions and predictors of progression. Clinical, angiographic, and genetic data were analyzed. RESULTS: Among 624 patients with ICAS, 458 were diagnosed with MMD at the last follow-up. Of these, 33 patients with bilaterally preserved terminal ICAs subsequently progressed to MMD over a median interval of 55.3 months (IQR, 12.5-97.3), representing 7.2% of all MMD cases. Among the 66 hemispheres in patients with MMD progression, M1 stenosis was the most common initial lesion (54.5%), followed by A1 (12.1%) and C2 stenosis (7.6%). RNF213 p.R4810K genotyping was performed in 304 patients, of whom 74.0% harbored the mutation. Multivariable Cox regression analysis showed that the RNF213 p.R4810K mutation (HR, 20.2; 95% CI, 2.63-155; P = 0.004) and younger age (HR per 1-year increase, 0.953; 95% CI, 0.931-0.975; P < 0.001) were independently associated with progression to MMD. CONCLUSION: The pre-moyamoya stage is characterized by heterogeneous stenotic patterns, with M1 steno-occlusive lesions representing the most common initial manifestation. RNF213 p.R4810K genotyping may help identify patients at increased risk of progression to MMD.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sasagasako et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: